
1. Moving the Markets
Just when it looked like stocks would never go up again, the tide shifted slightly on Monday with the Dow edging higher by 52 points, relieving some of the bearish pressure that has weighed on Wall Street since the start of the year. Now, investors are eyeing a hoped-for bounce after plunging 6% last week and dipping to what Wall Street calls extremely “oversold levels.”
Equities staged another late day rally today, sending the Dow up 117 points, as Wall Street managed to post a second straight day of gains. But that’s not to say that investors didn’t see another volatile trading session. U.S. stocks initially posted big gains early following a day of market stability in China. That rally fizzled after a renewed dip in oil prices. But stocks reversed course again and moved higher late in the day.
Helping matters was a rise in the value of the Chinese currency, the yuan, for the third straight day. Prior to the recent streak of gains, the yuan (renminbi) had lost value vs. the USD for eight straight trading sessions, which suggested that China’s economy was worse off than previously believed.
There aren’t many people who feel bad for oil companies. But the implosion in oil prices, which briefly pushed the price of U.S. Crude below $30 a barrel Tuesday for the first time since 2003, is causing a profit decline that almost invokes pity. The companies in the S&P 500 energy sector are expected to lose a collective $28.8 billion this calendar year, down from $95.4 billion in net income earned during the industry’s bonanza year of 2008.
All of our 10 ETFs in the Spotlight participated in the rebound and closed up. Leading the field was Healthcare (XLV) with +1.28%, while the Select Dividend ETF (DVY) lagged with +0.10%.


US equities are expected to give single-digit returns this year though the initial days look a little bad, said Bob Doll of Nuveen Asset Management. The current market turmoil looks a lot like August last year with plenty of similarities.
While the debate among market participants rages about the frequency of rate increases in 2016, investors worried about capital protection may consider an industry first fixed-income product product since not all bonds would get hammered with the gradual normalization of interest rates.